4
Changes in Ownership
Spyre Therapeutics, Inc. Filed Acc 0001140361-17-045127
Director bought 17,121 shares at an average $4.86 ($83,177)
From the SEC's structured data for this filing
Trades in this filing
Quinn Anthony G. · Director
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2017-12-01 | Purchase : show line 1 in the form | +4,100 | $4.53 | $18,578 | 14,100 | D |
| 2017-12-04 | Purchase : show line 2 in the form | +7,956 | $4.98 | $39,624 | 22,056 | D |
| 2017-12-05 | Purchase : show line 3 in the form | +5,065 | $4.93 | $24,976 | 27,121 | D |
| Open-market purchases · 17,121 sh · avg $4.86 · $83,177 | ||||||
Loading xslF345X03/doc1.xml…